Cytori Therapeutics Inc (CYTX) Stock Price & Overview
NASDAQ:CYTX
The current stock price of CYTX is 0.2077 null. Today CYTX is down by -5.59%. In the past month the price decreased by -18.55%. In the past year, price decreased by -69.9%.
CYTX Key Statistics
- Market Cap
- 4.602M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.42
- Dividend Yield
- N/A
CYTX Stock Performance
CYTX Stock Chart
CYTX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CYTX. When comparing the yearly performance of all stocks, CYTX is a bad performer in the overall market: 95.53% of all stocks are doing better.
CYTX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CYTX. CYTX may be in some trouble as it scores bad on both profitability and health.
CYTX Earnings
CYTX Forecast & Estimates
CYTX Financial Highlights
Over the last trailing twelve months CYTX reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS increased by 29.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -312.24% | ||
| ROA | -46.21% | ||
| ROE | -294.92% | ||
| Debt/Equity | 0.39 |
CYTX Ownership
About CYTX
Company Profile
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Company Info
Cytori Therapeutics Inc
3020 CALLAN ROAD
SAN DIEGO CA 92121
CEO: Marc. H. Hedrick
Phone: 858-458-0900
Cytori Therapeutics Inc / CYTX FAQ
What does CYTX do?
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
What is the current price of CYTX stock?
The current stock price of CYTX is 0.2077 null. The price decreased by -5.59% in the last trading session.
What is the dividend status of Cytori Therapeutics Inc?
CYTX does not pay a dividend.
What is the ChartMill rating of Cytori Therapeutics Inc stock?
CYTX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the ownership structure of Cytori Therapeutics Inc (CYTX)?
You can find the ownership structure of Cytori Therapeutics Inc (CYTX) on the Ownership tab.